share_log

Replimune Begins RP2 Clinical Trials With First Patients Enrolled In Metastatic Uveal Melanoma And Hepatocellular Carcinoma

Replimune Begins RP2 Clinical Trials With First Patients Enrolled In Metastatic Uveal Melanoma And Hepatocellular Carcinoma

Replimune开始进行RP2临床试验,首批患者已在转移性葡萄膜黑色素瘤和肝细胞癌中入组。
Benzinga ·  01/08 21:08

Advancing Its Oncolytic Immunotherapy Platform Following RP1 BLA Submission And Breakthrough Therapy Designation

在提交RP1生物制剂许可申请和突破性疗法认定后,推进其溶瘤免疫疗法平台

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发